• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CBER

Robert F Kennedy Jr US President Donald Trumps nominee for Secretary of Health and Human Services testifies during hi
Biotech

At cell and gene roundtable, officials pledge to slash regulations

Panelists discussed the need for relaxed regulation, the threat of Chinese competition and the groundbreaking recent case of a custom CRISPR therapy.
Darren Incorvaia Jun 5, 2025 2:50pm
flat earth

FDA leadership 'decapitated,' former leader Janet Woodcock says

Apr 7, 2025 4:04pm
FDA

CBER deputy director departs amid mass exodus

Feb 21, 2025 5:20pm
An illustration of a liver and a multicolored strand of DNA

Moderna rare disease drug nabs spot in FDA pilot program

Jun 7, 2024 6:10am
rare diseases

FDA picks Denali, Neurogene and more for rare disease program

Jun 4, 2024 2:51pm
pave smooth road path clear pavement asphalt

FDA's new platform guidance aims to smooth regulatory encounters

May 30, 2024 7:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings